ZAPOLSKII, VIKTOR; BURGI, MARÍA DE LOS MILAGROS; OGGERO MARCOS; BOLLATI-FOGOLÍN, MARIELA; KAUFMANN, DIETER

Chemistry of polyhalogenated nitrobutadienes, 19: Synthesis of new types of compound modulating the biological activity of Type I Interferons (IFN-I)

ARKIVOC - ONLINE JOURNAL OF ORGANIC CHEMISTRY; Lugar: Florida; Año: 2023

BOURGUIGNON, NATALIA; KARP, PAOLA; ATTALLAH, CAROLINA; CHAMORRO, DANIEL A.; OGGERO, MARCOS; BOOTH, ROSS; FERRERO, SOL; BHANSALI, SHEKHAR; PÉREZ, MAXIMILIANO S.; LERNER, BETIANA; HELGUERA, GUSTAVO

Large Area Microfluidic Bioreactor for Production of Recombinant Protein

Biosensors; Lugar: Basel; Año: 2022 vol. 12

AGUILAR, MARÍA FERNANDA; GARAY, A. SERGIO; ATTALLAH, CAROLINA; RODRIGUES, DANIEL E.; OGGERO, MARCOS

Changes in antibody binding and functionality after humanizing a murine scFv anti-IFN-α2: From in silico studies to experimental analysis

MOLECULAR IMMUNOLOGY; Año: 2022 vol. 151 p. 193 - 203

SALES, MARÍA DE LOS MILAGROS; KRATJE, RICARDO; OGGERO, MARCOS; CEAGLIO, NATALIA

Bifunctional GM-CSF-derived peptides as tools for O-glycoengineering and protein tagging

JOURNAL OF BIOTECHNOLOGY; Año: 2021 vol. 327 p. 18 - 27

GUGLIOTTA, AGUSTINA; LEOPOLD, MARÍA JESÚS; MUFARREGE, EDUARDO; ETCHEVERRIGARAY, MARINA; KRATJE, RICARDO; CEAGLIO, NATALIA; OGGERO, MARCOS

Pharmacokinetics Versus In Vitro Antiproliferative Potency to Design a Novel Hyperglycosylated hIFN-α2 Biobetter

PHARMACEUTICAL RESEARCH; Lugar: New York; Año: 2021

BÜRGI, MILAGROS; APARICIO, GABRIELA INÉS; DORELLA, AQUILES; KRATJE, RICARDO; SCORTICATI, CAMILA; OGGERO, MARCOS

Novel erythropoietin-based therapeutic candidates with extra N-glycan sites that block hematopoiesis but preserve neuroplasticity

Biotechnology Journal; Lugar: Weinheim; Año: 2021 vol. 16 p. 1 - 14

GIORGETTI, SOFÍA INÉS; ETCHEVERRIGARAY, MARINA; TERRY, FRANCES; MARTIN, WILLIAM; DE GROOT, ANNE SEARLS; CEAGLIO, NATALIA; OGGERO, MARCOS; MUFARREGE, EDUARDO FEDERICO

Development of highly stable and de-immunized versions of recombinant alpha interferon: Promising candidates for the treatment of chronic and emerging viral diseases

CLINICAL IMMUNOLOGY; Año: 2021 vol. 233

BURGI, MARÍA DE LOS MILAGROS; APARICIO, GABRIELA; KRATJE RICARDO; SCORTICATI, CAMILA; OGGERO, MARCOS

Abstracts from the 26th European Society for Animal Cell Technology Meeting - Cell culture technologies: bridging academia and industry to provide solutions for patients

BMC Proceedings; Lugar: Londres; Año: 2020 vol. 14 p. 18 - 20

ATTALLAH, C.; AGUILAR, MF.; FORNO, A. G.; ETCHEVERRIGARAY, M.; BRIGIDO, MARCELO; MARANHAO, ANDREA; OGGERO, M.

The glycosylation of anti-rhIFN-α2b recombinant antibodies influences the antigen-neutralizing activity

BIOTECHNOLOGY LETTERS; Año: 2020

BÜRGI, MILAGROS; HERNÁNDEZ, PAOLA; CABRERA, MAURICIO; CERECETTO, HUGO; GONZÁLEZ, MERCEDES; KRATJE, RICARDO; RAIMONDI, ALEJANDRO; OGGERO, MARCOS; BOLLATI-FOGOLÍN, MARIELA

Identification and characterization of human Interferon alpha inhibitors through a wish cell line–based reporter gene assay

BIOORGANIC CHEMISTRY; Año: 2020 vol. 94

ATTALLAH, CAROLINA; RODRIGUES, MA. CELESTE; LOZANO, VICTORIA; ETCHEVERRIGARAY MARINA; OGGERO, MARCOS

Design and validation of an immuno-PCR assay for IFN-alpha2b quantification in human plasma

BIOANALYSIS; Lugar: Londres; Año: 2019

ABUD, J.E.; SANTAMARÍA, C.G.; OGGERO, M.; RODRIGUEZ, H.A.

Methodological aspects of Universal immuno-PCR on standard tubes

ANALYTICAL BIOCHEMISTRY; Año: 2019 vol. 570 p. 56 - 61

GUGLIOTTA, AGUSTINA; CEAGLIO, NATALIA; KRATJE, RICARDO; OGGERO, MARCOS

Effect of ANITVNITV peptide fusion on the bioactivity and pharmacokinetics of human IFN-α2b and a hyper-N-glycosylated variant

JOURNAL OF BIOTECHNOLOGY; Año: 2019 vol. 303 p. 46 - 52

GUGLIOTTA, AGUSTINA; CEAGLIO, NATALIA; ETCHEVERRIGARAY, MARINA; KRATJE, RICARDO; OGGERO, MARCOS

Strategies to develop therapeutic N- and O-hyperglycosylated proteins

METHODS IN MOLECULAR BIOLOGY (CLIFTON, N.J.); Año: 2018 vol. 1674 p. 163 - 181

BOURGUIGNON, NATALIA; ATTALLAH, CAROLINA; KARP, PAOLA; BOOTH, ROSS; PEÑAHERRERA, ANA; PAYÉS, CRISTIAN; OGGERO, MARCOS; PÉREZ, MAXIMILIANO S.; HELGUERA, GUSTAVO; LERNER, BETIANA

Production of monoclonal antibodies in microfluidic devices

INTEGRATIVE BIOLOGY; Lugar: CAMBRIDGE; Año: 2018

ATTALLAH, CAROLINA; AGUILAR, MARÍA FERNANDA; GARAY, A. SERGIO; HERRERA, FERNANDO E.; ETCHEVERRIGARAY, MARINA; OGGERO, MARCOS; RODRIGUES, DANIEL E.

An unusual cysteine V L 87 affects the antibody fragment conformations without interfering with the disulfide bond formation

MOLECULAR IMMUNOLOGY; Año: 2017 vol. 90 p. 143 - 149

CAROLINA ATTALLAH; MARINA ETCHEVERRIGARAY; RICARDO KRATJE; MARCOS OGGERO

A highly efficient modified human serum albumin signal peptide to secrete proteins in cells derived from different mammalian species

PROTEIN EXPRESSION AND PURIFICATION; Lugar: Amsterdam; Año: 2017 vol. 132 p. 27 - 33

NATALIA CEAGLIO; AGUSTINA GUGLIOTTA; MARÍA BELÉN TARDIVO; DIANELA CRAVERO; MARINA ETCHEVERRIGARAY; RICARDO KRATJE; MARCOS OGGERO

Improvement of in vitro stability and pharmacokinetics of hIFN-alpha by fusing the carboxyl-terminal peptide of hCG β-subunit

JOURNAL OF BIOTECHNOLOGY; Lugar: Amsterdam; Año: 2016 vol. 221 p. 13 - 24

AGUSTINA GUGLIOTTA; NATALIA CEAGLIO; BRENDA RAUD; GUILLERMINA FORNO; LAURA MAURO; RICARDO KRATJE; MARCOS OGGERO

Glycosylation and antiproliferative activity of hyperglycosylated IFN-alpha2 potentiate HEK293 cells as biofactories

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS; Lugar: Amsterdam; Año: 2016

BURGI, MARÍA DE LOS MILAGROS; ZAPOLSKII, VIKTOR; HINKELMANN, BETTINA; KÖSTER, MARIO; KAUFMANN, DIETER; SASSE, FLORENZ; HAUSER, HANSJÖRG; ETCHEVERRIGARAY, MARINA; KRATJE, RICARDO; BOLLATI-FOGOLÍN, MARIELA; OGGERO, MARCOS

Screening and characterization of molecules that modulate the biological activity of IFNs-I

JOURNAL OF BIOTECHNOLOGY; Lugar: Amsterdam; Año: 2016 vol. 233 p. 6 - 16

ATTALLAH, C; ETCHEVERRIGARAY, M.; OGGERO, M.

Empleo de distintos péptidos señales para expresión de proteínas recombinantes en células HEK293, NS0 y CHO-K1

FABICIB - Revista de la FBCB/UNL; Lugar: Santa Fe; Año: 2015 vol. 19 p. 138 - 140

GUGLIOTTA, AGUSTINA; OGGERO, MARCOS; ETCHEVERRIGARAY, MARINA; KRATJE, RICARDO; CEAGLIO, NATALIA

Differences in the production of hyperglycosylated IFN alpha in CHO and HEK 293 cells

BMC Proceedings; Año: 2013 vol. 7 p. 1 - 3

NORMA PEROTTI; MARINA ETCHEVERRIGARAY; RICARDO KRATJE; MARCOS OGGERO

A versatile ionic strength sensitive tag from a human GM-CSF-derived linear epitope

PROTEIN EXPRESSION AND PURIFICATION; Lugar: Amsterdam; Año: 2013 vol. 91 p. 10 - 19

NATALIA CEAGLIO; GUSTAVO OROZCO; MARINA ETCHEVERRIGARAY; MÓNICA MATTIO; RICARDO KRATJE; NORMA PEROTTI; MARCOS OGGERO

High performance collection of cerebrospinal fluid in rats: Evaluation of erythropoietin penetration after osmotic opening of the blood-brain barrier

JOURNAL OF NEUROSCIENCE METHODS; Lugar: Amsterdam; Año: 2013 vol. 219 p. 70 - 75

MARÍA DE LOS MILAGROS BURGI; CLAUDIO PRIETO; MARINA ETCHEVERRIGARAY; RICARDO KRATJE; MARCOS OGGERO; MARIELA BOLLATI-FOGOLÍN

Wish Cell Line: From the Antiviral System to a Novel Reporter Gene Assay to Test the Potency of Human IFN-alfa; and IFN-beta

JOURNAL OF IMMUNOLOGICAL METHODS; Lugar: Amsterdam; Año: 2012 vol. 381 p. 70 - 74

MILAGROS BURGI; CLAUDIO PRIETO; MARCOS OGGERO; MARIELA BOLLATI-FOGOLÍN; MARINA ETCHEVERRIGARAY; RICARDO KRATJE

New reporter cell clones to determine the biological activity of human type I interferons

BMC Proceedings; Año: 2011 p. 1 - 2

MÓNICA MATTIO; NATALIA CEAGLIO; MARCOS OGGERO; NORMA PEROTTI; IGNACIO AMADEO; GUSTAVO OROZCO; GUILLERMINA FORNO; RICARDO KRATJE; MARINA ETCHEVERRIGARAY

Isolation and characterization of a subset of erythropoietin glycoforms with cytoprotective but minimal erythropoietic activity

Biotechnology Progress; Año: 2011 vol. 27 p. 1018 - 1028

MARINA ETCHEVERRIGARAY; NATALIA CEAGLIO; MÓNICA MATTIO; MARCOS OGGERO; IGNACIO AMADEO; GUILLERMINA FORNO; NORMA PEROTTI; RICARDO KRATJE

Neuroprotective activity of a new erythropoietin formulation with increased penetration in the central nervous system

BMC Proceedings; Año: 2011 p. 1 - 3

CEAGLIO, N.; ETCHEVERRIGARAY, M.; KRATJE, R. B.; OGGERO EBERHARDT, M.

Influence of carbohydrates on the stability and structure of a hyperglycosylated human interferon alpha mutein

BIOCHIMIE; Lugar: Amsterdam; Año: 2010 vol. 92 p. 971 - 978

CEAGLIO, N.; ETCHEVERRIGARAY, M.; CONRADT, H.; GRAMMEL, N.; KRATJE, R. B.; OGGERO EBERHARDT, M.

Highly glycosylated human alpha interferon: an insight into a new therapeutic candidate

JOURNAL OF BIOTECHNOLOGY; Lugar: Amsterdam; Año: 2010 vol. 146 p. 74 - 83

CEAGLIO, N.; ETCHEVERRIGARAY, M.; KRATJE, R. B.; OGGERO EBERHARDT, M.

Novel long-lasting interferon alpha derivatives designed by glycoengineering

BIOCHIMIE; Lugar: Amsterdam; Año: 2008 vol. 90 p. 437 - 449

DEPETRIS, M.; CASALIS, P.; KRATJE, R. B.; ETCHEVERRIGARAY, M.; OGGERO EBERHARDT, M.

A scFv antibody fragment as a therapeutic candidate to neutralize a broad diversity of human IFN-alpha subtypes

JOURNAL OF IMMUNOLOGICAL METHODS; Lugar: Amsterdam; Año: 2008 vol. 334 p. 104 - 113

OGGERO EBERHARDT, M.; FORNO, A. G.; KRATJE, R. B.; ETCHEVERRIGARAY, M.

Rational selection of an antibody probe to detect the heterogeneous collection of CHO-derived rhGM CSF glycoforms

BIOTECHNOLOGY LETTERS; Lugar: Dordrecht; Año: 2006 vol. 28 p. 2049 - 2056

OGGERO EBERHARDT, M.; FRANK, R.; ETCHEVERRIGARAY, M.; KRATJE, R. B.

Defining the antigenic structure of human GM CSF and its implications for receptor interaction and therapeutic treatments

MOLECULAR DIVERSITY; Lugar: Dordrecht; Año: 2004 vol. 8 p. 257 - 269

AMADEO, G.; OGGERO EBERHARDT, M.; ZENCLUSSEN, M. L.; ROBLES, L.; PEREIRA, D.; KRATJE, R. B.; ETCHEVERRIGARAY, M.

A single monoclonal antibody as probe to detect the entire set and partially unfolded rhEPO glycoforms

JOURNAL OF IMMUNOLOGICAL METHODS; Lugar: Amsterdam; Año: 2004 vol. 293 p. 191 - 205

FORNO, A. G.; BOLLATI FOGOLÍN M. R.; OGGERO EBERHARDT, M.; KRATJE, R. B.; ETCHEVERRIGARAY, M.; CONRADT, H.; NIMTZ, M.

N- and O-linked carbohydrates and glycosylation site occupancy in recombinant human granulocyte-macrophage colony-stimulating factor secreted by a Chinese hamster ovary cell line

EUROPEAN JOURNAL OF BIOCHEMISTRY; Lugar: Oxford; Año: 2004 vol. 271 p. 907 - 919

OGGERO EBERHARDT, M.; FRANK, R.; KRATJE, R. B.; ETCHEVERRIGARAY, M.

Identification of two potential receptor-binding sites of hGM-CSF

BRAZILIAN JOURNAL OF CHEMICAL ENGINEERING; Lugar: São Paulo; Año: 2003 vol. 20 p. 15 - 20

CAMPERI, S. A.; IANUCCI, N. B.; ALBANESI, G.; OGGERO EBERHARDT, M.; ETCHEVERRIGARAY, M.; MESSEGUER, A.; ALBERICIO, F.; CASCONE, O.

Monoclonal antibody purification by affinity chromatography with ligands derived from the screening of peptide combinatory libraries

BIOTECHNOLOGY LETTERS; Lugar: Dordrecht; Año: 2003 vol. 25 p. 1545 - 1548

BOLLATI FOGOLÍN M. R.; OGGERO EBERHARDT, M.; KRATJE, R. B.; ETCHEVERRIGARAY, M.

Choice of the adequate quantification method for recombinant human GM-CSF produced in different host systems

ELECTRONIC JOURNAL OF BIOTECHNOLOGY; Lugar: Valparaíso; Año: 2002 vol. 5 p. 243 - 250

OGGERO EBERHARDT, M.; KRATJE, R. B.; ETCHEVERRIGARAY, M.

Actividad anti-rhGM-CSF en suero humano normal

FABICIB - Revista de la FBCB/UNL; Lugar: Santa Fe; Año: 2002 vol. 6 p. 57 - 67

DIDIER, C.; OGGERO EBERHARDT, M.; KRATJE, R. B.; ETCHEVERRIGARAY, M.

Evaluation of the releasing pharmacokinetics of depot preparations of Leuprolide

Transport Phenomena and Unit Operations ? Food Sience and Engineering Biotechnology; Lugar: Santa Fe; Año: 2001 vol. 3 p. 1753 - 1758

OGGERO EBERHARDT, M.; FRANK, R.; KRATJE, R. B.; ETCHEVERRIGARAY, M.

Identification of two potential receptor-binding sites of hGM-CSF

Transport Phenomena and Unit Operations ? Food Sience and Engineering Biotechnology; Lugar: Santa Fe; Año: 2001 vol. 3 p. 1807 - 1812

ALEANZI, M.; OGGERO EBERHARDT, M.; BOLLATI FOGOLÍN M. R.; MARCIPAR, A.; VIJAYALAKSHMI, M.

Ni-IMAC Purification of IgG3 Murine Monoclonal Antibody Against Trypanosoma Cruzi Glycoprotein Extract

International Journal of Bio-Chromatography; Lugar: Amsterdam; Año: 1998 vol. 4 p. 85 - 94